These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26912202)

  • 1. Structure-guided design of new indoles as negative allosteric modulators (NAMs) of N-methyl-D-aspartate receptor (NMDAR) containing GluN2B subunit.
    Buemi MR; De Luca L; Ferro S; Russo E; De Sarro G; Gitto R
    Bioorg Med Chem; 2016 Apr; 24(7):1513-9. PubMed ID: 26912202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists.
    Stroebel D; Buhl DL; Knafels JD; Chanda PK; Green M; Sciabola S; Mony L; Paoletti P; Pandit J
    Mol Pharmacol; 2016 May; 89(5):541-51. PubMed ID: 26912815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting GluN2B-containing N-Methyl-D-aspartate receptors: design, synthesis, and binding affinity evaluation of novel 3-substituted indoles.
    Buemi MR; De Luca L; Ferro S; Gitto R
    Arch Pharm (Weinheim); 2014 Aug; 347(8):533-9. PubMed ID: 24862313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological characterization of 3-substituted 1H-indoles as ligands of GluN2B-containing N-methyl-D-aspartate receptors. Part 2.
    Gitto R; De Luca L; Ferro S; Buemi MR; Russo E; De Sarro G; Chisari M; Ciranna L; Chimirri A
    J Med Chem; 2012 Dec; 55(23):10532-9. PubMed ID: 23140383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Structure-Activity Relationship of a Tetrahydroisoquinoline Class of N-Methyl-d-Aspartate Receptor Modulators that Potentiates GluN2B-Containing N-Methyl-d-Aspartate Receptors.
    Strong KL; Epplin MP; Bacsa J; Butch CJ; Burger PB; Menaldino DS; Traynelis SF; Liotta DC
    J Med Chem; 2017 Jul; 60(13):5556-5585. PubMed ID: 28586221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of a novel negative allosteric modulator of NMDA receptors, UBP792.
    Sapkota K; Burnell ES; Irvine MW; Fang G; Gawande DY; Dravid SM; Jane DE; Monaghan DT
    Neuropharmacology; 2021 Dec; 201():108818. PubMed ID: 34610288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors.
    Karakas E; Simorowski N; Furukawa H
    Nature; 2011 Jun; 475(7355):249-53. PubMed ID: 21677647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors.
    Mony L; Krzaczkowski L; Leonetti M; Le Goff A; Alarcon K; Neyton J; Bertrand HO; Acher F; Paoletti P
    Mol Pharmacol; 2009 Jan; 75(1):60-74. PubMed ID: 18923063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, modelling and biological characterization of 3-substituted-1H-indoles as ligands of GluN2B-containing N-methyl-d-aspartate receptors.
    Gitto R; De Luca L; Ferro S; Russo E; De Sarro G; Chisari M; Ciranna L; Alvarez-Builla J; Alajarin R; Buemi MR; Chimirri A
    Bioorg Med Chem; 2014 Feb; 22(3):1040-8. PubMed ID: 24411196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From NMDA receptor antagonists to discovery of selective σ₂ receptor ligands.
    Gitto R; De Luca L; Ferro S; Scala A; Ronsisvalle S; Parenti C; Prezzavento O; Buemi MR; Chimirri A
    Bioorg Med Chem; 2014 Jan; 22(1):393-7. PubMed ID: 24290063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological characterization of 3-substituted-1H-indoles as ligands of GluN2B-containing N-methyl-D-aspartate receptors.
    Gitto R; De Luca L; Ferro S; Buemi MR; Russo E; De Sarro G; Costa L; Ciranna L; Prezzavento O; Arena E; Ronsisvalle S; Bruno G; Chimirri A
    J Med Chem; 2011 Dec; 54(24):8702-6. PubMed ID: 22050212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indole derivatives as dual-effective agents for the treatment of neurodegenerative diseases: synthesis, biological evaluation, and molecular modeling studies.
    Buemi MR; De Luca L; Chimirri A; Ferro S; Gitto R; Alvarez-Builla J; Alajarin R
    Bioorg Med Chem; 2013 Aug; 21(15):4575-80. PubMed ID: 23777828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GluN2B-selective N-methyl-D-aspartate (NMDA) receptor antagonists derived from 3-benzazepines: synthesis and pharmacological evaluation of benzo[7]annulen-7-amines.
    Benner A; Bonifazi A; Shirataki C; Temme L; Schepmann D; Quaglia W; Shoji O; Watanabe Y; Daniliuc C; Wünsch B
    ChemMedChem; 2014 Apr; 9(4):741-51. PubMed ID: 24677663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of 3-substituted-1H-indole derivatives as NR2B/NMDA receptor antagonists.
    Gitto R; De Luca L; Ferro S; Citraro R; De Sarro G; Costa L; Ciranna L; Chimirri A
    Bioorg Med Chem; 2009 Feb; 17(4):1640-7. PubMed ID: 19157884
    [